propranolol has been researched along with Schizophrenia in 125 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with chronic schizophrenia were treated with either propranolol (640 mg daily) or thioridazine (400 mg daily)." | 9.05 | The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia. ( Eccleston, D; Fairbairn, AF; Hassanyeh, F; McClelland, HA; Stephens, DA, 1985) |
| "Propranolol contributed usefully to the practical management of patients with chronic schizophrenia whose florid symptoms had not remitted with major tranquillisers." | 9.04 | Propranolol as an adjunct to the treatment of schizophrenia. ( Gruzelier, JH; Hollander, D; Pitcher, DR; Sergeant, HG; Yorkston, NJ; Zaki, SA, 1977) |
| "A 25-year-old male developed sinus tachycardia after given clozapine for treatment-resistant psychosis in schizophrenia." | 7.78 | [Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis]. ( Bosch, TM; Hovens, JE; Mookhoek, EJ; van Dam, D, 2012) |
| "Large doses (960 to 3200 mg/day) of propranolol were taken by eight patients with chronic schizophrenia in a double-blind therapeutic trial." | 7.67 | Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia. ( Linnoila, M; Ninan, PT; Scheinin, M; van Kammen, DP, 1984) |
| "Early results for an uncontrolled study of 555 patients with florid schizophrenia suggest that propranolol can be used safely in high dosage, and in a proportion of cases it appears to control schizophrenic symptoms." | 7.65 | Safeguards in the treatment of schizophrenia with propranolol. ( Havard, CW; Themen, JF; Yorkston, NJ; Zaki, SA, 1976) |
| "Propranolol was shown to have a more beneficial effect than placebo, but the results were much less dramatic than those which have been described in previous studies." | 6.65 | Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication. ( Priest, RG; Pugh, CR; Steinert, J, 1983) |
| "Propranolol was associated with a significant temporary increase in HVA, a non-significant rise in 5-HIAA and a significant decrease in MHPG, in the lumbar cerebrospinal fluid of 4 patients." | 6.65 | Some clinical and metabolic aspects of propranolol in chronic schizophrenia. ( King, DJ; Kinney, CD; Liddle, J; Turkson, SN, 1980) |
| " Clinically, propranolol, an agent of this group, has been investigated in the treatment of various clinical disorders including schizophrenia, other psychoses, anxiety disorders, and stress reactions." | 6.15 | Propranolol in psychiatry. Therapeutic uses and side effects. ( Ananth, J; Lin, KM, 1986) |
| "Propranolol in plasma was positively correlated to dosage." | 5.26 | Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings. ( Alfredsson, G; Hanssen, T; Heyden, T; Nybäck, H; Sundberg, I; Wetterberg, L, 1980) |
| "Propranolol was found to facilitate habituation in slow habituators and to reinstate responses in half of non-responders, especially when given as the sole drug." | 5.26 | Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia. ( Connolly, J; Eves, F; Gruzelier, J; Hirsch, S; Weller, M; Yorkston, N; Zaki, S, 1981) |
| "propranolol." | 5.26 | High-dose propranolol in schizophrenia. ( Sheppard, GP, 1979) |
| "Propranolol was found to share the properties of the racemate in facilitating habituation of the electrodermal orienting reflex in schizophrenic patients." | 5.26 | Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia. ( Gruzelier, JH; Hirsch, SR; Murphy, C; Weller, M, 1979) |
| " Fifty subjects met the DSM-III-R criteria for schizophrenia or schizoaffective disorder, participated in a 10-week, double-blind comparison of haloperidol and clozapine and a 1-year, open-label clozapine trial, and had available serum glucose and lipid levels." | 5.10 | Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment. ( Ball, P; Baymiller, SP; Buchanan, RW; McMahon, RP, 2003) |
| "Patients with chronic schizophrenia were treated with either propranolol (640 mg daily) or thioridazine (400 mg daily)." | 5.05 | The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia. ( Eccleston, D; Fairbairn, AF; Hassanyeh, F; McClelland, HA; Stephens, DA, 1985) |
| "Propranolol contributed usefully to the practical management of patients with chronic schizophrenia whose florid symptoms had not remitted with major tranquillisers." | 5.04 | Propranolol as an adjunct to the treatment of schizophrenia. ( Gruzelier, JH; Hollander, D; Pitcher, DR; Sergeant, HG; Yorkston, NJ; Zaki, SA, 1977) |
| " Among the more important recent discoveries are the efficacy of the tricyclic antidepressants for panic disorder and agoraphobia with panic attacks; the use of the monoamine oxidase inhibitors for the above disorders and for atypical depression and hysteroid dysphoria; the use of propranolol for anxiety disorders and for uncontrollable violent outbursts; the antianxiety and antipanic effects of clonidine; and the usefulness of lithium in treating schizophrenia and schizoaffective disorder and for emotionally unstable character disorders." | 4.76 | Newer uses for older psychotropic medications. ( Liebowitz, MR, 1982) |
| "A 25-year-old male developed sinus tachycardia after given clozapine for treatment-resistant psychosis in schizophrenia." | 3.78 | [Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis]. ( Bosch, TM; Hovens, JE; Mookhoek, EJ; van Dam, D, 2012) |
| "These results suggest that propranolol may be useful for the treatment of polydipsia in patients with schizophrenia." | 3.70 | Is propranolol effective in primary polydipsia? ( Endo, S; Kishi, Y; Kurosawa, H, 1998) |
| "Large doses (960 to 3200 mg/day) of propranolol were taken by eight patients with chronic schizophrenia in a double-blind therapeutic trial." | 3.67 | Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia. ( Linnoila, M; Ninan, PT; Scheinin, M; van Kammen, DP, 1984) |
| "Recent reports have suggested that high doses of propranolol may be an effective treatment in schizophrenia." | 3.66 | The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin. ( Belmaker, RH; Dasberg, H; Ebstein, RP; Levy, A; Sedvall, G; Van Praag, HM, 1979) |
| "Early results for an uncontrolled study of 555 patients with florid schizophrenia suggest that propranolol can be used safely in high dosage, and in a proportion of cases it appears to control schizophrenic symptoms." | 3.65 | Safeguards in the treatment of schizophrenia with propranolol. ( Havard, CW; Themen, JF; Yorkston, NJ; Zaki, SA, 1976) |
| "Suicidal ideation was significantly associated with clinician observed akathisia, depressed mood, younger age, and use of propranolol." | 2.77 | Akathisia and suicidal ideation in first-episode schizophrenia. ( Gaebel, W; Gastpar, M; Heuser, I; Jäger, M; Klingenberg, S; Klosterkötter, J; Lewitzka, U; Maier, W; Mayr, A; Möller, HJ; Musil, R; Ohmann, C; Riedel, M; Schennach, R; Schlösser, R; Schmitt, A; Schneider, F; Seemüller, F, 2012) |
| "Propranolol was shown to have a more beneficial effect than placebo, but the results were much less dramatic than those which have been described in previous studies." | 2.65 | Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication. ( Priest, RG; Pugh, CR; Steinert, J, 1983) |
| "Propranolol was associated with a significant temporary increase in HVA, a non-significant rise in 5-HIAA and a significant decrease in MHPG, in the lumbar cerebrospinal fluid of 4 patients." | 2.65 | Some clinical and metabolic aspects of propranolol in chronic schizophrenia. ( King, DJ; Kinney, CD; Liddle, J; Turkson, SN, 1980) |
| "Propranolol was administered because of clozapine-induced tachycardia." | 2.58 | Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review. ( Jurin, H; Medved, S; Medved, V; Ostojić, Z, 2018) |
| "Treatment with risperidone for 8 weeks, but not 2 or 4 weeks, significantly improved working memory performance." | 1.34 | Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task. ( Dawe, GS; Lim, EP; Nagarajah, R; Verma, V, 2007) |
| " Neuroleptic medications are still the mainstay of treatment, but recent studies suggest new approaches to dosage and to the treatment of acute psychosis." | 1.27 | The pharmacologic treatment of schizophrenia: a progress report. ( Baldessarini, RJ; Donaldson, SR; Gelenberg, AJ, 1983) |
| "Propranolol was found to be an effective treatment of tardive akathisia in both patients." | 1.27 | Propranolol in the treatment of tardive akathisia: a report of two cases. ( Iskandar, H; Nastase, C; Yassa, R, 1988) |
| "Propranolol was found to share the properties of the racemate in facilitating habituation of the electrodermal orienting reflex in schizophrenic patients." | 1.26 | Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia. ( Gruzelier, JH; Hirsch, SR; Murphy, C; Weller, M, 1979) |
| "Propranolol was administered in 8 equal doses over 24 hours and increased at a daily rate of 400 mg." | 1.26 | beta-adrenergic blocking drugs in psychiatry: present status, future approaches and research. ( Atsmon, A; Blum, I, 1978) |
| "Propranolol was found to facilitate habituation in slow habituators and to reinstate responses in half of non-responders, especially when given as the sole drug." | 1.26 | Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia. ( Connolly, J; Eves, F; Gruzelier, J; Hirsch, S; Weller, M; Yorkston, N; Zaki, S, 1981) |
| "propranolol." | 1.26 | High-dose propranolol in schizophrenia. ( Sheppard, GP, 1979) |
| "Propranolol in plasma was positively correlated to dosage." | 1.26 | Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings. ( Alfredsson, G; Hanssen, T; Heyden, T; Nybäck, H; Sundberg, I; Wetterberg, L, 1980) |
| "Toxic effects (ataxia, visual hallucinations, and confusional states) were related to the rate of increase rather than to the absolute dose of propranolol." | 1.25 | Propranolol in the control of schizophrenic symptoms. ( Havard, CW; Malik, MK; Morrison, RC; Yorkston, NJ; Zaki, SA, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 104 (83.20) | 18.7374 |
| 1990's | 13 (10.40) | 18.2507 |
| 2000's | 4 (3.20) | 29.6817 |
| 2010's | 4 (3.20) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, S | 1 |
| Hu, J | 1 |
| Zhu, X | 1 |
| Shang, D | 1 |
| Wen, Y | 1 |
| Qiu, C | 1 |
| Medved, S | 1 |
| Ostojić, Z | 1 |
| Jurin, H | 1 |
| Medved, V | 1 |
| van Dam, D | 1 |
| Bosch, TM | 1 |
| Mookhoek, EJ | 1 |
| Hovens, JE | 1 |
| Seemüller, F | 1 |
| Schennach, R | 1 |
| Mayr, A | 1 |
| Musil, R | 1 |
| Jäger, M | 1 |
| Maier, W | 1 |
| Klingenberg, S | 1 |
| Heuser, I | 1 |
| Klosterkötter, J | 1 |
| Gastpar, M | 1 |
| Schmitt, A | 1 |
| Schlösser, R | 1 |
| Schneider, F | 1 |
| Ohmann, C | 1 |
| Lewitzka, U | 1 |
| Gaebel, W | 1 |
| Möller, HJ | 1 |
| Riedel, M | 1 |
| Baymiller, SP | 1 |
| Ball, P | 1 |
| McMahon, RP | 1 |
| Buchanan, RW | 1 |
| Gibson, CA | 1 |
| Stewart, JT | 1 |
| Lim, EP | 1 |
| Verma, V | 1 |
| Nagarajah, R | 1 |
| Dawe, GS | 1 |
| Sahoo, S | 1 |
| Ameen, S | 1 |
| Bacher, NM | 1 |
| Lewis, HA | 2 |
| Lindström, LH | 1 |
| Persson, E | 1 |
| Gruzelier, J | 2 |
| Thornton, S | 1 |
| Staniforth, D | 1 |
| Zaki, S | 2 |
| Yorkston, N | 3 |
| Peet, M | 5 |
| Middlemiss, DN | 2 |
| Yates, RA | 3 |
| Connolly, J | 1 |
| Eves, F | 1 |
| Hirsch, S | 1 |
| Weller, M | 2 |
| Wilbur, R | 2 |
| Kulik, FA | 1 |
| Malas, KL | 1 |
| de Fraites, EG | 1 |
| van Kammen, DP | 3 |
| Liebowitz, MR | 1 |
| Staniforth, DH | 1 |
| Yorkston, NJ | 6 |
| Zaki, SA | 6 |
| Kafka, MS | 1 |
| Perényi, A | 1 |
| Farkas, A | 1 |
| Bacher, NA | 1 |
| Karniol, IG | 1 |
| Portela, W | 1 |
| Richardson-Andrews, RC | 1 |
| Kulik, AV | 1 |
| Pugh, CR | 2 |
| Steinert, J | 1 |
| Priest, RG | 1 |
| Donaldson, SR | 1 |
| Gelenberg, AJ | 1 |
| Baldessarini, RJ | 1 |
| Johnson, JM | 1 |
| Dominguez, RA | 1 |
| Goldstein, BJ | 1 |
| Ratey, JJ | 3 |
| Salzman, C | 1 |
| King, DJ | 5 |
| Cooper, SJ | 3 |
| Liddle, J | 2 |
| Scheinin, M | 1 |
| Ninan, PT | 1 |
| Linnoila, M | 1 |
| Belmaker, RH | 4 |
| Zohar, J | 2 |
| Ebstein, RP | 3 |
| Bannet, J | 1 |
| Drummer, D | 1 |
| Fisch, R | 1 |
| Epstein, RP | 1 |
| Morrill, R | 1 |
| Oxenkrug, G | 1 |
| Sethi, BB | 1 |
| Dubé, S | 1 |
| Chiu, E | 2 |
| Turkson, SN | 1 |
| Kinney, CD | 1 |
| Weller, MP | 2 |
| Gruzelier, JH | 4 |
| Hirsch, SR | 4 |
| Bethell, MS | 1 |
| Coates, A | 1 |
| Khamnee, AK | 1 |
| Hall, P | 1 |
| Myers, DH | 1 |
| Campbell, PL | 1 |
| Cocks, NM | 1 |
| Flowerdew, JA | 1 |
| Muir, A | 1 |
| Streiner, DL | 1 |
| Manchanda, R | 5 |
| Elizur, A | 4 |
| Segal, Z | 3 |
| Yeret, A | 4 |
| Ben-David, M | 3 |
| Christie, MJ | 1 |
| Hanssen, T | 3 |
| Heyden, T | 3 |
| Sundberg, I | 3 |
| Alfredsson, G | 1 |
| Nybäck, H | 1 |
| Wetterberg, L | 3 |
| Vieweg, V | 1 |
| Pandurangi, A | 1 |
| Levenson, J | 1 |
| Silverman, J | 1 |
| Sachdev, P | 1 |
| Loneragan, C | 1 |
| Vanelle, JM | 1 |
| Metzer, WS | 1 |
| Paige, SR | 1 |
| Newton, JE | 1 |
| Remington, G | 1 |
| Fornazzari, L | 1 |
| Sethna, R | 1 |
| Kalian, M | 1 |
| Lerner, V | 1 |
| Goldman, M | 1 |
| Kishi, Y | 1 |
| Kurosawa, H | 1 |
| Endo, S | 1 |
| Hermesh, H | 2 |
| Manor, I | 1 |
| Munitz, H | 2 |
| Green, AR | 1 |
| Grahame-Smith, DG | 1 |
| Atsmon, A | 4 |
| Blum, I | 3 |
| Lubbe, WF | 1 |
| Davidson, S | 1 |
| Steinhert, J | 1 |
| Aboo-Shach, M | 1 |
| Segal, S | 1 |
| Pitcher, DR | 2 |
| Hollander, D | 2 |
| Sergeant, HG | 2 |
| Ridges, AP | 1 |
| Lawton, K | 1 |
| Harper, P | 1 |
| Ghosh, C | 1 |
| Hindson, N | 1 |
| Nasrallah, HA | 1 |
| Freed, WJ | 1 |
| Rogol, A | 1 |
| Wyatt, RJ | 2 |
| Eneroth, P | 1 |
| Dasberg, H | 1 |
| Levy, A | 1 |
| Sedvall, G | 1 |
| Van Praag, HM | 2 |
| Borison, RL | 1 |
| Diamond, BI | 1 |
| Biederman, J | 1 |
| Stern, R | 1 |
| Berman, M | 1 |
| Iveson-Iveson, J | 1 |
| Schoenen, J | 1 |
| Delwaide, PJ | 1 |
| Koehler, K | 1 |
| Guth, W | 1 |
| Wilson, JD | 1 |
| Sheridan, B | 1 |
| Sheppard, GP | 1 |
| Murphy, C | 1 |
| Crawford, JP | 1 |
| Themen, JF | 1 |
| Havard, CW | 2 |
| Shopsin, B | 1 |
| Hirsch, J | 1 |
| Gershon, S | 1 |
| Llorca, PM | 1 |
| Wolf, MA | 1 |
| Christison, GW | 1 |
| Kirch, DG | 1 |
| Adler, LA | 2 |
| Angrist, B | 6 |
| Rotrosen, J | 6 |
| Goldstein, MB | 1 |
| Folsom, T | 1 |
| Adler, L | 4 |
| Duncan, E | 1 |
| Hemdal, P | 1 |
| Slotnick, V | 1 |
| Frost, L | 1 |
| Lal, S | 1 |
| Yassa, R | 2 |
| Kim, A | 1 |
| Kramer, MS | 2 |
| Gorkin, R | 1 |
| DiJohnson, C | 2 |
| Doherty, MM | 1 |
| Peselow, E | 2 |
| Corwin, J | 2 |
| Tuross, N | 1 |
| Patrick, RL | 1 |
| Maslansky, R | 1 |
| Meltzer, HY | 1 |
| Sommers, AA | 1 |
| Luchins, DJ | 1 |
| Molcho, A | 1 |
| Iskandar, H | 1 |
| Nastase, C | 1 |
| Irwin, M | 1 |
| Sullivan, G | 1 |
| Van Putten, T | 1 |
| Gorkin, RA | 1 |
| Sheves, P | 1 |
| Lipinski, JF | 1 |
| Keck, PE | 1 |
| McElroy, SL | 1 |
| Berlant, JL | 1 |
| Ananth, J | 1 |
| Lin, KM | 1 |
| Sands, S | 1 |
| O'Driscoll, G | 1 |
| Eccleston, D | 1 |
| Fairbairn, AF | 1 |
| Hassanyeh, F | 1 |
| McClelland, HA | 1 |
| Stephens, DA | 1 |
| Gardos, G | 2 |
| Cole, JO | 1 |
| Volicer, L | 1 |
| Orzack, MH | 2 |
| Oliff, AC | 1 |
| Rackensperger, W | 1 |
| Gaupp, R | 1 |
| Mattke, DJ | 1 |
| Schwarz, D | 1 |
| Stutte, KH | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
| Greer, S | 1 |
| Parsons, V | 1 |
| Malik, MK | 1 |
| Morrison, RC | 1 |
| Steiner, M | 2 |
| Latz, A | 1 |
| Wijsenbeek, H | 1 |
| Branconnier, R | 1 |
| Lake, CR | 1 |
| Fann, WE | 1 |
| Stein, L | 1 |
| Dally, P | 1 |
| Maoz, B | 1 |
| Wysenbeek, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia[NCT00159120] | Phase 4 | 71 participants (Anticipated) | Interventional | 2001-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for propranolol and Schizophrenia
| Article | Year |
|---|---|
Takotsubo cardiomyopathy after the first electroconvulsive therapy regardless of adjuvant beta-blocker use: a case report and literature review.
Topics: Adrenergic beta-Antagonists; Adult; Electroconvulsive Therapy; Humans; Male; Propranolol; Schizophre | 2018 |
Is propranolol antischizophrenic?
Topics: Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Kinetics; | 1981 |
Newer uses for older psychotropic medications.
Topics: Adrenergic beta-Antagonists; Agoraphobia; Anxiety Disorders; Bipolar Disorder; Clonidine; Depressive | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognit | 1994 |
[Resistant schizophrenia: what chemotherapy?].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Carbam | 1993 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
[Use of certain cardiological drugs in the treatment of schizophrenia: review of the literature].
Topics: Antipsychotic Agents; Calcium Channel Blockers; Clinical Trials as Topic; Clonidine; Humans; Propran | 1991 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind M | 1991 |
Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
Topics: Adrenergic beta-Agonists; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; D | 1988 |
One more look at propranolol for the treatment of refractory schizophrenia.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Propranolol; Random Allocation; Schizophrenia | 1987 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
Neurochemistry of reward and punishment: some implications for the etiology of schizophrenia.
Topics: Animals; Ascorbic Acid; Bipolar Disorder; Brain; Dopamine; Feeding Behavior; Humans; Hypothalamus; M | 1971 |
43 trials available for propranolol and Schizophrenia
| Article | Year |
|---|---|
Akathisia and suicidal ideation in first-episode schizophrenia.
Topics: Adult; Age Factors; Akathisia, Drug-Induced; Antipsychotic Agents; Depression; Double-Blind Method; | 2012 |
Serum glucose and lipid changes during the course of clozapine treatment: the effect of concurrent beta-adrenergic antagonist treatment.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Antipsychotic Agents; Atenolol; Blood Gluc | 2003 |
Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
Topics: Adult; Antipsychotic Agents; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Delayed-Acti | 1980 |
Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.
Topics: Adult; Chlorpromazine; Drug Interactions; Female; Humans; Kinetics; Male; Middle Aged; Propranolol; | 1980 |
Neuroendocrine effects of D,L-propranolol.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Hydrocortisone; Luteinizing Hormone; Prolacti | 1981 |
Is propranolol antischizophrenic?
Topics: Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Kinetics; | 1981 |
Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Femal | 1982 |
Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; D | 1983 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Beta-blockers in psychiatry.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1984 |
The effect of propranolol on CSF amine metabolites in psychiatric patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Glycols; Homovanillic Acid; Humans; Hydrox | 1983 |
Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Pl | 1980 |
DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Proprano | 1981 |
Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.
Topics: Blood Pressure; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; | 1981 |
Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Mi | 1981 |
A trial of propranolol in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1981 |
Intravenous benztropine and propranolol challenges in tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Benztropine; Cross-Over Studies; Double-Blind Method; Dyski | 1993 |
Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Topics: Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Dyskine | 1993 |
Placebo response in refractory tardive akathisia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Diazepam; Double-Blind Method; Humans; Male; Middle A | 1993 |
Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Female; Humans; | 1979 |
Propranolol as an adjunct to the treatment of schizophrenia.
Topics: Adult; Blood Pressure; Chlorpromazine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up | 1977 |
Propranolol in schizophrenia.
Topics: Adult; Clinical Trials as Topic; Humans; Middle Aged; Propranolol; Schizophrenia | 1977 |
Decrease in serum-prolactin after propranolol in schizophrenia.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Prolactin; Propranolol; Schizoph | 1978 |
[Indications for beta-blockers in neurology].
Topics: Alcoholism; Antiparkinson Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Huma | 1978 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind M | 1991 |
Metoprolol versus propranolol.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Metoprolol; Middle Aged; Neurologic E | 1990 |
Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisia.
Topics: Adrenergic beta-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; | 1989 |
Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Benztropine; Dose-Response Relationship, Drug; Double | 1989 |
Tardive dystonia. The benefits of time.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dys | 1989 |
Efficacy of propranolol in neuroleptic-induced akathesia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Female; Humans; Lorazepam; Ma | 1985 |
Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Haloperidol; | 1986 |
A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; | 1986 |
The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Topics: Alprazolam; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Dextroamphetamine; Dose | 1986 |
Propranolol as a primary treatment of neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; | 1988 |
Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Double-Blind Method; Humans; Male; Mi | 1988 |
Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
Topics: Adrenergic beta-Agonists; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; D | 1988 |
Dextro-propranolol and depressive symptoms in a schizophrenic population.
Topics: Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Propranolol; Psychiatric | 1987 |
One more look at propranolol for the treatment of refractory schizophrenia.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Propranolol; Random Allocation; Schizophrenia | 1987 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Huma | 1985 |
A dose-response study of propranolol in chronic schizophrenics.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Behavior; Blood Glucose; Blood Pressure; Calcium; Chron | 1973 |
[Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Blood Pressure; Catatonia; Clinical Trials as Top | 1974 |
Psychopharmacology.
Topics: Alcoholism; Anxiety; Brain Damage, Chronic; Chronic Disease; Clinical Trials as Topic; Depression; E | 1970 |
74 other studies available for propranolol and Schizophrenia
| Article | Year |
|---|---|
Sleepwalking Is Associated With Coadministration of Olanzapine and Propranolol: A Case Report.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combinatio | 2017 |
[Treatment of clozapine-induced tachycardia with propranolol complicated by psoriasis].
Topics: Adrenergic beta-Antagonists; Adult; Antipsychotic Agents; Clozapine; Humans; Male; Propranolol; Psor | 2012 |
Treatment of psychogenic polydipsia with pindolol.
Topics: Adrenergic beta-Antagonists; Antipsychotic Agents; Drinking Behavior; Humans; Hypotension; Male; Mid | 2006 |
Propranolol blocks chronic risperidone treatment-induced enhancement of spatial working memory performance of rats in a delayed matching-to-place water maze task.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; | 2007 |
Acute nocturnal akathisia induced by clozapine.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Ci | 2007 |
Low-dose propranolol in tardive dyskinesia.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Male; Midd | 1980 |
Active and passive avoidance learning in controls and schizophrenic patients on racemic propranolol and neuroleptics.
Topics: Adult; Antipsychotic Agents; Avoidance Learning; Drug Therapy, Combination; Humans; Middle Aged; Pro | 1980 |
Propranolol in schizophrenia--more guess than Gauss.
Topics: Humans; Male; Probability; Propranolol; Schizophrenia | 1980 |
Effect of propranolol and phenothiazines on electrodermal orienting and habituation in schizophrenia.
Topics: Acoustic Stimulation; Adolescent; Adult; Antipsychotic Agents; Attention; Chlorpromazine; Drug Thera | 1981 |
Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; | 1980 |
Dose dependent changes in propranolol half life when used as an adjunct to neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combi | 1982 |
alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs.
Topics: Adenylyl Cyclases; Adult; Antipsychotic Agents; Blood Platelets; Cell Membrane; Cyclic AMP; Female; | 1983 |
Propranolol in the treatment of tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Prop | 1983 |
Propranolol, anxiety, and tardive dyskinesia.
Topics: Antipsychotic Agents; Anxiety; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Proprano | 1983 |
A central role for the polyamines in the aetiology of schizophrenia.
Topics: Antipsychotic Agents; Brain; Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Polya | 1983 |
Case report of propranolol (Inderal) pharmacotherapy for neuroleptic-induced akathisia and tremor.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Ind | 1983 |
The pharmacologic treatment of schizophrenia: a progress report.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Ca | 1983 |
Recognizing and managing akathisia.
Topics: Adrenergic beta-Antagonists; Akathisia, Drug-Induced; Anti-Anxiety Agents; Antipsychotic Agents; Ben | 1984 |
Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia.
Topics: Adult; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Evaluation; Female; Homovanil | 1984 |
Cyclic nucleotides in mental disorder.
Topics: Adolescent; Adult; Bipolar Disorder; Cyclic AMP; Cyclic GMP; Female; Glucagon; Humans; Lithium; Male | 1980 |
The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
Topics: Adult; Chronic Disease; Depressive Disorder; Dihydroalprenolol; Double-Blind Method; Female; Humans; | 1983 |
Use of propranolol for provoked and unprovoked episodes of rage.
Topics: Adult; Aggression; Anger; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Propranolol; | 1983 |
Propranolol in schizophrenia.
Topics: Adult; Humans; Male; Propranolol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psy | 1983 |
Priority in the pharmacological management of chronic schizophrenia: the quality of life issues.
Topics: Chronic Disease; Humans; Propranolol; Psychotropic Drugs; Quality of Life; Schizophrenia | 1982 |
Propranolol in schizophrenia.
Topics: Chronic Disease; Humans; Propranolol; Schizophrenia | 1982 |
Propranolol in schizophrenia.
Topics: Humans; Propranolol; Schizophrenia; Statistics as Topic | 1982 |
Dextro-propranolol in schizophrenia.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Propranolol; Psychiatric Status Rating Scales; Schiz | 1980 |
Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; | 1980 |
Interesting uses of beta blockers (2): propranolol in schizophrenia.
Topics: Adult; Humans; Propranolol; Schizophrenia | 1981 |
Electrodermal activity in the 1980s: a review.
Topics: Affective Disorders, Psychotic; Anxiety Disorders; Electrodes; Galvanic Skin Response; Humans; Metho | 1981 |
Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Melatonin; | 1980 |
Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; | 1993 |
Is propranolol effective in primary polydipsia?
Topics: Adrenergic beta-Antagonists; Adult; Drinking; Female; Humans; Male; Middle Aged; Obsessive Behavior; | 1998 |
Propranolol: a treatment for pseudoakathisia.
Topics: Adult; Agnosia; Akathisia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Perphenazine; Propr | 1994 |
Beta-adrenergic blockade in the control of schizophrenic symptoms--a case for controlled studies.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; | 1975 |
(-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system.
Topics: Adrenergic beta-Antagonists; Animals; Brain; Dopamine; Humans; Motor Activity; Propranolol; Rats; Re | 1976 |
beta-adrenergic blocking drugs in psychiatry: present status, future approaches and research.
Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Psychotic Disorders; Schizophrenia | 1978 |
Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers.
Topics: Adrenergic beta-Antagonists; Aged; Female; Humans; Middle Aged; Oxprenolol; Propranolol; Psychoses, | 1979 |
[The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; | 1979 |
Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Male; Prolactin; Propranolol; Schizoph | 1979 |
Effect of propranolol on serum-melatonin.
Topics: Adult; Circadian Rhythm; Female; Humans; Melatonin; Propranolol; Schizophrenia | 1977 |
Propranolol in schizophrenia.
Topics: Drug Evaluation; Humans; Placebos; Propranolol; Schizophrenia | 1977 |
Propranolol in chronic schizophrenia.
Topics: Blood Pressure; Chronic Disease; Drug Evaluation; Humans; Placebos; Propranolol; Pulse; Schizophreni | 1977 |
Propranolol and prolactin.
Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Male; Prolactin; Propranolo | 1977 |
The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin.
Topics: Adult; Biogenic Amines; Female; Humans; Male; Middle Aged; Prolactin; Propranolol; Pulse; Schizophre | 1979 |
A new animal model for schizophrenia: interactions with adrenergic mechanisms.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Ditiocarb; Drug Antagonism; Dr | 1978 |
The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; | 1978 |
A new approach to schizophrenia.
Topics: Brain Chemistry; Humans; Propranolol; Schizophrenia | 1977 |
[Schizophrenia-like psychosis following administration of propranol].
Topics: Acute Disease; Adult; Humans; Male; Propranolol; Psychoses, Substance-Induced; Schizophrenia; Vertig | 1977 |
Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.
Topics: Chronic Disease; Humans; Male; Metoclopramide; Prolactin; Propranolol; Psychiatric Status Rating Sca | 1979 |
High-dose propranolol in schizophrenia.
Topics: Adult; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Prolactin; Propra | 1979 |
Influence of D-or DL-propranolol and chlorpromazine on habituation of phasic electrodermal responses in schizophrenia.
Topics: Adolescent; Adult; Chlorpromazine; Female; Galvanic Skin Response; Habituation, Psychophysiologic; H | 1979 |
Dystonic reaction to high dose propranolol.
Topics: Adult; Female; Humans; Muscular Diseases; Propranolol; Schizophrenia | 1977 |
Safeguards in the treatment of schizophrenia with propranolol.
Topics: Dose-Response Relationship, Drug; Female; Humans; Male; Propranolol; Schizophrenia | 1976 |
Visual hallucinations and propranolol.
Topics: Administration, Oral; Blood Pressure; Hallucinations; Humans; Male; Propranolol; Pulse; Schizophreni | 1975 |
Efficacy of betaxolol in neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Betaxolol; Drug Administration Schedule; Human | 1991 |
The successful treatment of psychogenic polydipsia and water intoxication with propanolol. A case report.
Topics: Adult; Chronic Disease; Drinking; Humans; Male; Propranolol; Schizophrenia; Schizophrenic Psychology | 1991 |
Neuroleptic-induced marching-in-place.
Topics: Adult; Antipsychotic Agents; Benztropine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; | 1989 |
Efficacy of low-dose metoprolol in neuroleptic-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, D | 1989 |
Effects of propranolol on catecholamine synthesis and uptake in the central nervous system of the rat.
Topics: Animals; Antipsychotic Agents; Brain; Catecholamines; Corpus Striatum; Dose-Response Relationship, D | 1986 |
Beta-adrenergic blockers for aggressive behavior in schizophrenia.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Antipsychotic Agents; Drug Therapy, Combination; Hum | 1987 |
Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Diazepam; Female; Humans; Male; Propranolol; P | 1988 |
Propranolol in the treatment of tardive akathisia: a report of two cases.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Female; Humans; Propranolol; Psychomotor Agitat | 1988 |
Propranolol--the wonder drug for psychiatric disorders?
Topics: Anxiety Disorders; Humans; Mental Disorders; Propranolol; Schizophrenia | 1988 |
Criteria for measuring change: statistical significance vs clinical significance.
Topics: Humans; Propranolol; Schizophrenia; Thioridazine | 1986 |
The phenomenology of recovery in a chronic schizophrenic.
Topics: Adult; Chronic Disease; Humans; Male; Propranolol; Schizophrenia; Schizophrenic Psychology | 1986 |
Schizophrenia-like psychosis in thyroid crisis.
Topics: Adult; Antithyroid Agents; Chlorpromazine; Diagnosis, Differential; Humans; Hyperthyroidism; Male; P | 1968 |
New drug for schizophrenia?
Topics: Chlorpromazine; Drug Synergism; Heart Arrest; Humans; Hypoglycemia; Hypotension; Phenothiazines; Pro | 1974 |
Propranolol in the control of schizophrenic symptoms.
Topics: Adult; Ataxia; Confusion; Female; Hallucinations; Humans; Male; Middle Aged; Phenothiazines; Propran | 1974 |
Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion.
Topics: Acute Disease; Adult; Ataxia; Catecholamines; Chronic Disease; Female; Glycols; Humans; Hypertension | 1972 |
CNS effects of propranolol in man.
Topics: Adult; Central Nervous System; Cerebral Cortex; Chronic Disease; Electroencephalography; Evoked Pote | 1973 |
Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism.
Topics: Haloperidol; Humans; Hyperthyroidism; Male; Middle Aged; Propranolol; Schizophrenia; Spasm; Thyroid | 1973 |
The present status of psychotropic drugs.
Topics: Antidepressive Agents; Chlormethiazole; Diazepam; Dibenzazepines; Fluphenazine; Haloperidol; Humans; | 1970 |
[The effects of adrenergic blocking agents on psychotic patients].
Topics: Adolescent; Adult; Aged; Blood Pressure; Female; Humans; Male; Middle Aged; Propranolol; Psychotic D | 1970 |